Repression of type-1 fimbriae in Shiga toxin-producing Escherichia coli O91:H21 isolated from asymptomatic human carriers in Korea

J Microbiol Biotechnol. 2013 May;23(5):731-7. doi: 10.4014/jmb.1211.11080.

Abstract

Seventy-four Shiga toxin-producing Escherichia coli (STEC) isolates belonging to the serotype O91:H21 were isolated from 1,643 asymptomatic human carriers in a STEC outbreak at Gwangju in Korea. Although the isolates did not cause any symptoms, all of them produced Shiga toxins 1 (Stx1) and 2 (Stx2). In order to determine why these strains cause no symptoms, we explored the differences in virulence potential between the asymptomatic STEC O91:H21 isolates and symptomatic STEC O91:H21 strains (ATCC 51435 and ATCC 51434). The asymptomatic STEC O91:H21 isolates showed strongly reduced cytopathic effects compared with the symptomatic strains when intact bacterial cells were used as an inoculant. Moreover, we found a reduced adherence phenotype when testing asymptomatic strains on HeLa cells. Real-time quantitative PCR results suggest that transcriptional repression of the genes encoding type-1 fimbriae occurs in the asymptomatic isolates but not in the symptomatic strains.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carrier State / microbiology*
  • Cell Line
  • Down-Regulation*
  • Escherichia coli Infections / diagnosis
  • Escherichia coli Infections / epidemiology
  • Escherichia coli Infections / microbiology*
  • Escherichia coli Proteins / genetics
  • Escherichia coli Proteins / metabolism*
  • Fimbriae, Bacterial / genetics
  • Fimbriae, Bacterial / metabolism*
  • Humans
  • Republic of Korea / epidemiology
  • Shiga Toxin / metabolism*
  • Shiga-Toxigenic Escherichia coli / genetics
  • Shiga-Toxigenic Escherichia coli / isolation & purification
  • Shiga-Toxigenic Escherichia coli / metabolism*
  • Virulence Factors / genetics
  • Virulence Factors / metabolism

Substances

  • Escherichia coli Proteins
  • Virulence Factors
  • Shiga Toxin